Related Experiment Video
Updated: Jan 13, 2026

Comparative Study on the Polysaccharide Contents and Antioxidant Activities of Hippophae rhamnoides subsp. sinensis and Hippophae gyantsensis
Published on: August 15, 2025
Two New Prunasinoids From the Leaves of Elaeocarpus bachmaensis and Their Antidiabetic Activity
Phan Thi Diem Tran1,2, Vu Thi Thanh Tam1, Tran Phuong Ha1
1Mientrung Institute for Scientific Research, Vietnam National Museum of Nature, Vietnam Academy of Science and Technology, Hue City, Vietnam.
Abstract:
Two new prunasines, 6'-O-p-trans-coumaroyl prunasin (1) and 6'-O-p-cis-coumaroyl prunasin (2), together with six known compounds, afzelin (3), tamarixetin 3-O-rhamnoside (4), mearnsitrin (5), cis-linalool-3,6-oxide β-D-glucopyranoside (6), n-hexyl-O-β-D-glucoside (7), and cucurbitacin F (8), were isolated from the leaves of Elaeocarpus bachmaensis collected in Bach Ma National Park, Vietnam. Their chemical structures were elucidated by one-dimensional nuclear magnetic resonance (1D-NMR), 2D-NMR, and high-resolution mass spectrometry spectra. Bioassays revealed that compound 6 inhibited α-amylase significantly with a half-maximal inhibitory concentration (IC50) value of 137.3 ± 14.4 µM, whereas compounds 1-5 inhibited α-glucosidase significantly with IC50 values ranging from 82.4 ± 10.4 to 160.0 ± 19.9 µM. These findings suggest that E. bachmaensis may serve as a promising natural source for the development of antidiabetic agents. This is the first report on the chemical composition and bioactivity of the E. bachmaensis species.
More Related Videos
09:21Inhibition of Aspergillus flavus Growth and Aflatoxin Production in Transgenic Maize Expressing the α-amylase Inhibitor from Lablab purpureus L.
Published on: February 15, 2019
08:20Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Glinides